Humana Inc. $HUM Shares Sold by Savant Capital LLC

Savant Capital LLC decreased its holdings in Humana Inc. (NYSE:HUMFree Report) by 68.8% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 4,885 shares of the insurance provider’s stock after selling 10,786 shares during the quarter. Savant Capital LLC’s holdings in Humana were worth $1,251,000 at the end of the most recent reporting period.

A number of other large investors also recently bought and sold shares of HUM. Montag A & Associates Inc. raised its holdings in Humana by 1,880.0% in the 4th quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock worth $25,000 after purchasing an additional 94 shares during the period. CoreCap Advisors LLC raised its holdings in Humana by 54.4% in the 4th quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider’s stock worth $27,000 after purchasing an additional 37 shares during the period. Rosenberg Matthew Hamilton raised its holdings in Humana by 136.0% in the 4th quarter. Rosenberg Matthew Hamilton now owns 118 shares of the insurance provider’s stock worth $30,000 after purchasing an additional 68 shares during the period. Larson Financial Group LLC raised its holdings in Humana by 114.1% in the 3rd quarter. Larson Financial Group LLC now owns 152 shares of the insurance provider’s stock worth $40,000 after purchasing an additional 81 shares during the period. Finally, Fulcrum Asset Management LLP acquired a new position in Humana in the 3rd quarter worth about $42,000. Institutional investors and hedge funds own 92.38% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on HUM shares. William Blair assumed coverage on Humana in a report on Wednesday, May 20th. They issued an “outperform” rating for the company. Evercore increased their target price on Humana from $195.00 to $250.00 in a report on Thursday, April 30th. The Goldman Sachs Group increased their target price on Humana from $158.00 to $195.00 and gave the company a “sell” rating in a report on Thursday, April 30th. Wells Fargo & Company cut Humana from a “cautious” rating to a “reduce” rating in a report on Wednesday, May 20th. Finally, Seaport Research Partners cut Humana to a “neutral” rating in a report on Wednesday, May 20th. Nine analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and four have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Humana presently has an average rating of “Hold” and a consensus price target of $272.65.

View Our Latest Research Report on HUM

Humana Price Performance

NYSE:HUM opened at $328.19 on Tuesday. Humana Inc. has a one year low of $163.11 and a one year high of $333.31. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.77 and a current ratio of 1.77. The stock has a market cap of $39.40 billion, a PE ratio of 35.10, a P/E/G ratio of 2.21 and a beta of 0.68. The stock has a 50 day moving average price of $235.19 and a 200 day moving average price of $229.58.

Humana (NYSE:HUMGet Free Report) last posted its quarterly earnings results on Wednesday, April 29th. The insurance provider reported $10.31 EPS for the quarter, beating the consensus estimate of $9.97 by $0.34. Humana had a return on equity of 10.45% and a net margin of 0.82%.The firm had revenue of $39.65 billion during the quarter, compared to analysts’ expectations of $39.37 billion. During the same quarter last year, the firm earned $11.58 earnings per share. The business’s revenue for the quarter was up 23.5% on a year-over-year basis. Humana has set its FY 2026 guidance at 9.000- EPS. Equities research analysts expect that Humana Inc. will post 9.01 EPS for the current fiscal year.

Humana Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be given a $0.885 dividend. This represents a $3.54 annualized dividend and a yield of 1.1%. The ex-dividend date is Friday, June 26th. Humana’s dividend payout ratio is presently 37.86%.

About Humana

(Free Report)

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.

Read More

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUMFree Report).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.